1. Articles from fiercemedicaldevices.com

  2. 1-3 of 3
    1. Canon in exclusive negotiations to acquire Toshiba Medical Systems for $6B

      Canon in exclusive negotiations to acquire Toshiba Medical Systems for $6B

      Canon has emerged as the exclusive bidder for Toshiba Medical Systems , beating out Fujifilm Holdings in the final round of discussions, and numerous others who were also reportedly interested, including Sony ( $SNE ), Konica Minolta and private equity players KKR, Bain Capital, the Carlyle Group and the U.K.'s Permira. Canon will have exclusive negotiating rights until March 18, during which the two sides will aim to hammer out the details of a final agreement, expected to be valued around ¥700 billion ($6 billion). "Toshiba has carried out a close evaluation of the overall proposals received from companies that expressed ...

      Read Full Article
    2. St. Jude says alternative imaging system is optimal during stenting procedures

      St. Jude says alternative imaging system is optimal during stenting procedures

      St. Jude Medical ( $STJ ) highlighted studies that demonstrate the effectiveness of optical coherence tomography during stenting procedures at the EuroPCR conference in Paris. OCT imaging or intravascular ultrasound is used during percutaneous coronary intervention to implant stents in the heart's coronary artery. St. Jude says that OCT can produces images with resolutions up to 10 times higher than intravascular ultrasound. Regardless of which paradigm is used, the images guide physicians' decisions during the procedure, such as the size of the stent to be implanted. Overexpansion can damage the surrounding tissue, while underexpansion, or a stent that's too small ...

      Read Full Article
    3. St. Jude launches $1B stock buyback after stock plunge

      St. Jude launches $1B stock buyback after stock plunge

      St. Jude Medical ( $STJ ) has authorized a $1 billion stock repurchase effort amid rumors that it's under the regulatory gun, a week after the company's shares took a dive over new concerns about the safety of its devices. The buyback "demonstrates the confidence our board and management team have in the long-term prospects for St. Jude Medical," CEO Dan Starks said in a statement. The company says it has about 308 million shares outstanding at the moment. After last year's recall of Riata ICD leads pilloried the companies profits, St. Jude faces fresh worry over Durata , the ...

      Read Full Article
    1-3 of 3
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks